ENETS Consensus Guidelines for the management of patients with digestive neuroendocrine neoplasms: colorectal neuroendocrine neoplasms. - Wikidata - awgldk - TriplyDB

ENETS Consensus Guidelines for the management of patients with digestive neuroendocrine neoplasms: colorectal neuroendocrine neoplasms.

ENETS Consensus Guidelines for the management of patients with digestive neuroendocrine neoplasms: colorectal neuroendocrine neoplasms.

http://www.wikidata.org/entity/Q37977321

about

Neuroendocrine Carcinomas of the Gastroenteropancreatic System: A Comprehensive Review PET tracers for somatostatin receptor imaging of neuroendocrine tumors: current status and review of the literature Gastroenteropancreatic Well-Differentiated Grade 3 Neuroendocrine Tumors: Review and Position Statement.Recurrence 30 Years after Surgical Resection of a Localized Rectal Neuroendocrine Tumor.Italian Association of Clinical Endocrinologists (AME) position statement: a stepwise clinical approach to the diagnosis of gastroenteropancreatic neuroendocrine neoplasms.Paraneoplastic brainstem encephalitis in a patient with exceptionally long course of a metastasized neuroendocrine rectum neoplasm.Factors associated with lymph node metastasis in radically resected rectal carcinoids: a systematic review and meta-analysis.Endoscopic mucosal resection of early stage colon neuroendocrine carcinoma.Full-thickness excision using transanal endoscopic microsurgery for treatment of rectal neuroendocrine tumors Dilemmas in Endoscopic Management of Rectal Neuroendocrine Tumors: A Case-Based Discussion.Advantage of endoscopic mucosal resection with a cap for rectal neuroendocrine tumors.Prognostic Significance of Defining L-Cell Type on the Biologic Behavior of Rectal Neuroendocrine Tumors in Relation with Pathological Parameters.Analysis of the factors affecting lymph node metastasis and the prognosis of rectal neuroendocrine tumors.Mixed Adenoneuroendocrine Carcinoma Causing Colonic Intussusception.Transanal endoscopic microsurgery as optimal option in treatment of rare rectal lesions: A single centre experience.Lymphovascular invasion in more than one-quarter of small rectal neuroendocrine tumors.Enhanced detection of lymphovascular invasion in small rectal neuroendocrine tumors using D2-40 and Elastica van Gieson immunohistochemical analysis.Clinicopathological Features and Prognostic Factors of Colorectal Neuroendocrine Neoplasms.Is endoscopic ultrasonography essential for endoscopic resection of small rectal neuroendocrine tumors?Endoscopic resection therapies for rectal neuroendocrine tumors: a systematic review and meta-analysis.Long-Term Clinical Outcomes of Rectal Neuroendocrine Tumors According to the Pathologic Status After Initial Endoscopic Resection: A KASID Multicenter Study.Review article: the investigation and management of rectal neuroendocrine tumours.Frequent Presence of Lymphovascular Invasion in Small Rectal Neuroendocrine Tumors on Immunohistochemical Analysis.Are small rectal neuroendocrine tumors safe?Excellent prognosis following endoscopic resection of patients with rectal neuroendocrine tumors despite the frequent presence of lymphovascular invasion.Efficacy and safety of endoscopic resection therapies for rectal carcinoid tumors: a meta-analysis.Endoscopic Resection for Small Rectal Neuroendocrine Tumors: Comparison of Endoscopic Submucosal Resection with Band Ligation and Endoscopic Submucosal Dissection.Evolving role of the endoscopist in management of gastrointestinal neuroendocrine tumors Current endoscopic ultrasound-guided approach to incidental subepithelial lesions: optimal or optional?Diagnosis and Management of Rectal Neuroendocrine Tumors.Efficacy of Precut Endoscopic Mucosal Resection for Treatment of Rectal Neuroendocrine Tumors.Medical Therapy of Gastrointestinal Neuroendocrine Tumors.The Ki-67 labeling index and lymphatic/venous permeation predict the metastatic potential of rectal neuroendocrine tumors.Short- and long-term outcomes of endoscopic resection of rectal neuroendocrine tumours: analyses according to the WHO 2010 classification.Neuroendocrine Rectal Tumors: Main Features and Management.Surveillance strategy for rectal neuroendocrine tumors according to recurrence risk stratification.Impact of Ga-68 DOTATOC PET/CT on the diagnosis and treatment of patients with multiple endocrine neoplasia.Association of Coloproctology of Great Britain & Ireland (ACPGBI): Guidelines for the Management of Cancer of the Colon, Rectum and Anus (2017) - Surgical Management.[Gastroenteropancreatic neuroendocrine tumors : targeted diagnostics and therapy].Identification of Phosphohistone H3 Cutoff Values Corresponding to Original WHO Grades but Distinguishable in Well-Differentiated Gastrointestinal Neuroendocrine Tumors.

P2860

Q26768483-4D3ECA02-06F0-4084-8461-2875B3BC644A Q26992201-445E4368-1361-4EE7-A25B-B98C431705D5 Q30249051-B8FA8CAF-94D1-4217-B7B3-923AA7CD62E4 Q33894731-D9E9D6EE-270D-444B-9C6E-229BC38D305B Q34157385-8F774BC5-57AD-4F08-8B6F-308489EC6F60 Q34270713-8B8E8B57-485D-4FDB-AFAC-D8002EA30505 Q34788991-A90718D6-8398-4568-B8C4-F4E3B19856D8 Q35204100-0A40D9FC-0055-46FF-A9E9-A86436B6B76A Q35942430-F6447C09-CC66-4A31-894D-49AF90555EB5 Q35969004-FF792BC8-FA5F-451C-B49D-8F9A82524BFA Q35970176-37E519DC-B1A5-45DA-9554-73822597C4C5 Q36187039-2A3662AE-0198-475E-93BF-8CF207C5A782 Q36375451-87CB1399-7ADD-4634-8F08-AB304B333B47 Q37156953-59CFFEE2-A4C9-4153-998A-CE1F8CAD0463 Q37263132-6D980F6B-2C7B-487B-A816-226AE770B1CE Q37411503-D63E603B-E712-4AFB-9CE1-2BB7802ABD0F Q37429944-AFB11878-5AF7-4CDC-AFF6-BBBA9B7DD835 Q37615044-277EB199-3EBD-40B8-9D58-ED9440F5BA74 Q37714364-4A47AEA3-B1FB-4269-AF90-3A7FD677B347 Q38151880-6A2531BC-EF60-42CF-A8CF-16AB99646642 Q38412977-93DBE104-E088-4863-A4E2-F3B3A015FC67 Q38865549-133FA504-A201-4DDA-9051-88C41DD7ADD7 Q39067172-EBB0AE7A-DEB6-4408-BEF3-EC3115B233AC Q40092822-53B9BA0B-7575-41EF-B67C-2019246FA6D2 Q40982909-9B4259B1-75FB-4984-AD64-3F71DC0B3CE9 Q41686445-EC4A1836-EEEA-415E-8ED1-7887568BEB9D Q41771847-C4AB1E59-C75C-42F3-83FE-9C75440B6F3C Q42337114-943CDB5C-71B4-4D0A-85AD-F9222E59A54A Q43195344-47D0EEE8-5ED3-4B15-B3A9-888E8383447C Q47145141-80F9852D-6A4C-4BFD-B0A6-6FBBC6817DF5 Q47153675-3AC2BBEA-1557-4B9B-86CA-3B3CA9A91225 Q47816626-A6B50370-D8A1-4EF6-99D4-38E77BE3D47F Q48067310-39CDA7F4-C55D-47B4-A7F1-11DFF3124F88 Q50760995-3BDEA304-D8D0-4525-87A6-61DD9AE4B67E Q50890438-4506E33C-B68A-427B-83A7-38D292900379 Q51178377-25BE4F98-D434-453D-B3B0-61C0C7B39DCF Q51320250-45E24A0C-4959-464E-9335-F6F8D88E13A2 Q52809017-568AE3A5-7CA4-4DF8-B3EA-2D2803E2E1ED Q53057084-1D3E1E64-872F-4D9F-893A-C2C161B098FF Q55078460-7E042C1D-09DA-47C3-B47F-C637FDFB90FE

P2860

ENETS Consensus Guidelines for the management of patients with digestive neuroendocrine neoplasms: colorectal neuroendocrine neoplasms.

http://www.wikidata.org/entity/Q37977321

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

ENETS Consensus Guidelines for ...... ctal neuroendocrine neoplasms.

@en

ENETS Consensus Guidelines for ...... ctal neuroendocrine neoplasms.

@nl

type

label

ENETS Consensus Guidelines for ...... ctal neuroendocrine neoplasms.

@en

ENETS Consensus Guidelines for ...... ctal neuroendocrine neoplasms.

@nl

prefLabel

ENETS Consensus Guidelines for ...... ctal neuroendocrine neoplasms.

@en

ENETS Consensus Guidelines for ...... ctal neuroendocrine neoplasms.

@nl

P1433

Q37977321-A67ACBDC-6E04-4B68-B780-D07A3357FCBD

P1476

Q37977321-A82F7689-660C-43D0-A84D-D63BC43653A6

P2093

Q37977321-49EB3F41-5DC5-45AF-A6F6-DDEA619070C0

Q37977321-4A0E6E73-A3E2-48F5-8BBE-D85E96090DD5

Q37977321-51F1C81B-7274-42ED-BB30-E0B030842C2F

Q37977321-548E1CDC-315C-470D-93AD-802EAFF358DA

Q37977321-5B9BB0D1-CE5E-4419-882C-B3E90E869DF8

Q37977321-63A71FF3-CF96-4E4D-9406-8983606E441C

Q37977321-63FD7B63-0C42-4F95-86A5-553753DDA783

Q37977321-7810820E-B940-47FD-889F-A394A29F569F

Q37977321-9960146D-5062-472A-84F1-7E1E57889DFB

Q37977321-F224B725-920C-4D4C-A746-49462B31F640

P304

Q37977321-11AE5B5A-2DEC-4FD5-8DC3-D374AA7D27B3

P31

Q37977321-EF49520C-48BE-4707-BF77-A74591364E1C

P356

Q37977321-590E6DC4-A803-427E-8F51-2EB372DF01A9

P433

Q37977321-AEA2E671-7417-475C-8991-75FEED607534

P478

Q37977321-41D09A2C-58F6-41A6-90CE-DD52006A17F6

P577

Q37977321-1EC5023E-417F-430B-91EC-5F0D01BD2881

P5875

Q37977321-575D671C-535C-4BFA-8D71-8A1EDE423078

P698

Q37977321-FD9DD1A5-F0FC-49E9-B5A6-4F4447BCD84A

P921

Q37977321-07141117-28F1-4579-A557-41ACF7DAF6FB

Q37977321-E62D56CF-9B1F-47AB-99B0-1A397505C84F

P356

P1433

Neuroendocrinology

P1476

ENETS Consensus Guidelines for ...... ctal neuroendocrine neoplasms.

@en

P2093

Anders Sundin

http://www.w3.org/2001/XMLSchema#string

Andreas Pascher

http://www.w3.org/2001/XMLSchema#string

Barcelona Consensus Conference participants

http://www.w3.org/2001/XMLSchema#string

Fahrettin Kelestimur

http://www.w3.org/2001/XMLSchema#string

Klaus J Klose

http://www.w3.org/2001/XMLSchema#string

Martyn Caplin

http://www.w3.org/2001/XMLSchema#string

Mauro Papotti

http://www.w3.org/2001/XMLSchema#string

Ola Nillson

http://www.w3.org/2001/XMLSchema#string

Ramon Salazar

http://www.w3.org/2001/XMLSchema#string

Richard P Baum

http://www.w3.org/2001/XMLSchema#string

P304

88-97

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1159/000335594

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

95

http://www.w3.org/2001/XMLSchema#string

P577

2012-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

221763508

http://www.w3.org/2001/XMLSchema#string

P698

22261972

http://www.w3.org/2001/XMLSchema#string

P921

neuroendocrinology